vs
Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
American Assets Trust, Inc. is the larger business by last-quarter revenue ($110.6M vs $57.3M, roughly 1.9× RHYTHM PHARMACEUTICALS, INC.). American Assets Trust, Inc. runs the higher net margin — 6.1% vs -83.0%, a 89.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 1.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -0.1%).
Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
AAT vs RYTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $110.6M | $57.3M |
| Net Profit | $6.7M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 23.4% | -82.2% |
| Net Margin | 6.1% | -83.0% |
| Revenue YoY | 1.8% | 36.9% |
| Net Profit YoY | -16.3% | -9.6% |
| EPS (diluted) | $0.08 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.6M | — | ||
| Q4 25 | $110.1M | $57.3M | ||
| Q3 25 | $109.6M | $51.3M | ||
| Q2 25 | $107.9M | $48.5M | ||
| Q1 25 | $108.6M | $32.7M | ||
| Q4 24 | $113.5M | $41.8M | ||
| Q3 24 | $122.8M | $33.3M | ||
| Q2 24 | $110.9M | $29.1M |
| Q1 26 | $6.7M | — | ||
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $4.5M | $-52.9M | ||
| Q2 25 | $5.5M | $-46.6M | ||
| Q1 25 | $42.5M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $16.7M | $-43.6M | ||
| Q2 24 | $11.9M | $-32.3M |
| Q1 26 | — | — | ||
| Q4 25 | 59.4% | 91.6% | ||
| Q3 25 | 60.5% | 89.3% | ||
| Q2 25 | 62.6% | 88.6% | ||
| Q1 25 | 62.0% | 88.8% | ||
| Q4 24 | 61.3% | 90.9% | ||
| Q3 24 | 65.5% | 88.5% | ||
| Q2 24 | 63.6% | 89.9% |
| Q1 26 | 23.4% | — | ||
| Q4 25 | 21.1% | -82.2% | ||
| Q3 25 | 22.6% | -102.6% | ||
| Q2 25 | 24.1% | -93.4% | ||
| Q1 25 | 66.3% | -143.7% | ||
| Q4 24 | 26.5% | -98.6% | ||
| Q3 24 | 30.8% | -132.0% | ||
| Q2 24 | 27.8% | -139.2% |
| Q1 26 | 6.1% | — | ||
| Q4 25 | — | -83.0% | ||
| Q3 25 | 4.1% | -103.1% | ||
| Q2 25 | 5.1% | -96.1% | ||
| Q1 25 | 39.2% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 13.6% | -131.2% | ||
| Q2 24 | 10.7% | -110.9% |
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | $-0.73 | ||
| Q3 25 | $0.07 | $-0.82 | ||
| Q2 25 | $0.09 | $-0.75 | ||
| Q1 25 | $0.70 | $-0.81 | ||
| Q4 24 | $0.14 | $-0.71 | ||
| Q3 24 | $0.28 | $-0.73 | ||
| Q2 24 | $0.20 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $118.3M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $139.1M |
| Total Assets | $2.9B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $118.3M | — | ||
| Q4 25 | $129.4M | $388.9M | ||
| Q3 25 | $138.7M | $416.1M | ||
| Q2 25 | $143.7M | $291.0M | ||
| Q1 25 | $143.9M | $314.5M | ||
| Q4 24 | $425.7M | $320.6M | ||
| Q3 24 | $533.0M | $298.4M | ||
| Q2 24 | $114.9M | $319.1M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | $139.1M | ||
| Q3 25 | $1.2B | $148.8M | ||
| Q2 25 | $1.2B | $-11.9M | ||
| Q1 25 | $1.2B | $18.9M | ||
| Q4 24 | $1.2B | $21.7M | ||
| Q3 24 | $1.2B | $11.2M | ||
| Q2 24 | $1.2B | $39.3M |
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $480.2M | ||
| Q3 25 | $2.9B | $506.9M | ||
| Q2 25 | $3.0B | $372.7M | ||
| Q1 25 | $3.0B | $386.7M | ||
| Q4 24 | $3.3B | $392.3M | ||
| Q3 24 | $3.4B | $363.6M | ||
| Q2 24 | $3.0B | $381.8M |
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.72× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 14.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $167.1M | $-25.4M | ||
| Q3 25 | $40.5M | $-26.6M | ||
| Q2 25 | $49.2M | $-23.3M | ||
| Q1 25 | $36.9M | $-40.4M | ||
| Q4 24 | $207.1M | $-18.8M | ||
| Q3 24 | $52.4M | $-25.2M | ||
| Q2 24 | $59.3M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $94.9M | — | ||
| Q3 25 | $23.1M | — | ||
| Q2 25 | $28.4M | — | ||
| Q1 25 | $20.4M | — | ||
| Q4 24 | $136.9M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $43.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 86.2% | — | ||
| Q3 25 | 21.1% | — | ||
| Q2 25 | 26.3% | — | ||
| Q1 25 | 18.8% | — | ||
| Q4 24 | 120.7% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 39.3% | — |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 65.6% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 15.1% | — | ||
| Q4 24 | 61.9% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 14.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 8.98× | — | ||
| Q2 25 | 9.01× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.15× | — | ||
| Q2 24 | 4.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
RYTM
Segment breakdown not available.
